Cipla recalling over 5.8 lakh packets of gastric ulcer treatment drug in US

11 Jan 2021 Evaluate

Cipla is recalling over 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the US market. The drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 40 mg in the US market.

The drug firm has manufactured the affected lot at its Kurkumbh facility in Maharashtra and then supplied to its New Jersey-based subsidiary. The USFDA cited ‘cross-contamination with other products’ as the reason for the company recalling the product.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1502.90 -8.00 (-0.53%)
01-Jan-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.05
Dr. Reddys Lab 1253.70
Cipla 1502.90
Zydus Lifesciences 909.80
Lupin 2088.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×